Literature DB >> 25447775

Phage display as a novel promising antivenom therapy: a review.

Eduardo Crosara Roncolato1, Lucas Benício Campos1, Gabriela Pessenda1, Luciano Costa e Silva1, Gilvan Pessoa Furtado1, José Elpidio Barbosa2.   

Abstract

In this work, we present recent advances in the use of phage display technology for the preparation of antivenoms for animal toxin neutralization. Even though classical antivenoms have been used since the early 20th century, envenomation remains a global public health problem. Recently, the phage display technique has been used in an attempt to circumvent some of the difficulties associated with traditional preparations of antivenom. Here, we review studies that developed antibody fragments with potential inhibitory effects against animal toxins and discuss the most current technical issues and perspectives regarding phage display technology in this field.
Copyright © 2014. Published by Elsevier Ltd.

Keywords:  Animal toxins; Antibodies; Antivenoms; Envenomation; New therapies; Phage display

Mesh:

Substances:

Year:  2014        PMID: 25447775     DOI: 10.1016/j.toxicon.2014.11.001

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  9 in total

1.  Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology.

Authors:  Ali Nazari; Maedeh Samianifard; Hadi Rabie; Abbas Zare Mirakabadi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-06-19

Review 2.  Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.

Authors:  Agata Anna Cisek; Iwona Dąbrowska; Karolina Paulina Gregorczyk; Zbigniew Wyżewski
Journal:  Curr Microbiol       Date:  2016-11-28       Impact factor: 2.188

3.  Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?

Authors:  Andreas H Laustsen; Kristoffer H Johansen; Mikael Engmark; Mikael R Andersen
Journal:  PLoS Negl Trop Dis       Date:  2017-02-03

4.  Toxinology provides multidirectional and multidimensional opportunities: A personal perspective.

Authors:  R Manjunatha Kini
Journal:  Toxicon X       Date:  2020-05-11

5.  Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims.

Authors:  R Manjunatha Kini; Sachdev S Sidhu; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2018-12-13       Impact factor: 4.546

6.  Preparation and Evaluation of a Horse Antiserum against the Venom of Sea Snake Hydrophis curtus from Hainan, China.

Authors:  Bo Wang; Guoyan Liu; Min Luo; Xin Zhang; Qianqian Wang; Shuaijun Zou; Fuhai Zhang; Xia Jin; Liming Zhang
Journal:  Toxins (Basel)       Date:  2022-04-01       Impact factor: 5.075

7.  In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Authors:  Andreas H Laustsen; Aneesh Karatt-Vellatt; Edward W Masters; Ana Silvia Arias; Urska Pus; Cecilie Knudsen; Saioa Oscoz; Peter Slavny; Daniel T Griffiths; Alice M Luther; Rachael A Leah; Majken Lindholm; Bruno Lomonte; José María Gutiérrez; John McCafferty
Journal:  Nat Commun       Date:  2018-10-02       Impact factor: 14.919

Review 8.  Basics of Antibody Phage Display Technology.

Authors:  Line Ledsgaard; Mogens Kilstrup; Aneesh Karatt-Vellatt; John McCafferty; Andreas H Laustsen
Journal:  Toxins (Basel)       Date:  2018-06-09       Impact factor: 4.546

9.  Antivenom Neutralization of Coagulopathic Snake Venom Toxins Assessed by Bioactivity Profiling Using Nanofractionation Analytics.

Authors:  Chunfang Xie; Julien Slagboom; Laura-Oana Albulescu; Ben Bruyneel; Kristina B M Still; Freek J Vonk; Govert W Somsen; Nicholas R Casewell; Jeroen Kool
Journal:  Toxins (Basel)       Date:  2020-01-16       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.